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PES (2-phenylethynesulfonamide) was initially identified as an inhibitor of p53 translocation to 
mitochondria and named Pifithrin-µ. Further studies showed that PES selectively killed tumour cells and 
was thus a promising anticancer agent. PES-induced cell death was characterised by a non-apoptotic, 
autophagosome-rich phenotype. We observed this phenotype via electron microscopy in wild type (wt) 
and double Bax-/- Bak-/- (DKO) mouse embryonic fibroblasts (MEFs) treated with PES. We excluded 
the involvement of effector caspases, BAX and BAK, in causing PES-triggered cell death. Therefore, 
apoptosis was ruled out as the lethal mode of action of PES. Surprisingly, MEFs containing BAX were 
significantly protected from PES treatments. BAX overexpression in Bax-/- MEFs confirmed this pro-
survival effect. Moreover, this protective effect required the ability of BAX to localise to mitochondrial 
membranes. Conversely, mitochondrial fusion induced by treatment with Mdivi-1 conferred increased 
resistance to MEFs subjected to PES treatment. The involvement of BAX in the regulation of 
mitochondrial dynamics has been reported. We propose the promotion of mitochondrial fusion by BAX 
to be the pro-survival function attributed to BAX. 
 







Pifithrins are small synthetic molecules that can inhibit the apoptosis-inducing functions of the 
p53 protein. Pifithrins were created to reduce the toxicity associated with radiation and chemotherapy in 
the context of cancer treatment, which is largely mediated by p53. Pifithrin-α was the first compound 
identified and characterised as an inhibitor of the transcriptional activity of p53 [1]. However, p53 can 
cause apoptotic cell death via mechanisms that are independent of transcription. For instance, p53 can 
translocate to mitochondria, interact with the anti-apoptotic members of the Bcl-2 family of proteins, 
neutralise them and cause apoptosis [2]. This fact prompted new analyses of chemical libraries and the 
discovery of pifithrin-µ. Pifithrin-µ can disrupt the interactions between the p53 and Bcl-2 proteins 
without modifying the transcriptional activity of p53. Consistently, it conferred a partial protection to mice 
subjected to γ-radiation [3].  
 Further studies demonstrated that pifithrin-µ was an effective inducer of cell death and that 
cancer cells are more sensitive to this drug [4,5]. The characterisation of this death process showed it to 
be independent of p53 and caspases. The cell morphology was characterised by increased 
vacuolisation and abundant autophagic vesicles. However, this change was not due to the promotion of 
autophagy but rather to the blockage of the autophagic flux. Therefore, proteotoxic stress, defined as 
the accumulation of misfolded proteins, was proposed as the mechanism of pifithrin-µ-induced cell 
death [4,6]. Moreover, in addition to p53, pifithrin-µ targeted the heat-shock protein 70 (HSP70) family of 
proteins [4,7]. The subsequent disruption of its chaperone function was very consistent with the 
resulting proteotoxicity. The identification of targets different from p53 prompted the renaming of 
pifithrin-µ to PES (the acronym of 2-phenylethynesulfonamide) [4]. We adhere to this naming convention 
hereafter. 
 Although HSP70 and proteotoxicity explained the lethal properties of PES quite satisfactorily, 
controversy arose about the type of cell death this drug induced. Some researchers were clearly finding 




finding canonical apoptotic processes [5,8,9]. Moreover, in pancreatic cell lines, a mixture of caspase-
dependent and independent processes were identified [10]. Most models of apoptosis depend on 
mitochondrial outer membrane permeabilisation (MOMP), an event mediated by the BAX and BAK 
proteins. These proteins define the intrinsic or mitochondrial pathway of apoptosis. Cells deficient in 
both proteins become totally resistant to apoptosis induction via the intrinsic pathway [11,12]. Double 
Bax-/- Bak-/- (DKO) mouse embryonic fibroblasts (MEFs) and their wild type (wt) counterparts provide 
the most conclusive system for assessing the implication of the mitochondrial mechanisms that trigger 
apoptosis. Our aim was to explore the lethal effects of PES on this system. Unexpectedly, we found that 
more wt MEFs survived than DKO MEFs after a treatment with PES. PES did not activate either the 
effector caspases or the intrinsic apoptotic pathway. Therefore, apoptosis could be excluded as the type 
of cell death triggered by PES. The protein BAX was identified as promoting the increase in cell survival 
in wt MEFs. Upon induction of mitochondrial fusion, we found that MEFs became more resistant to PES-
induced cell death. We hypothesised that the pro-survival action of BAX was based on the modulation 
of mitochondrial dynamics.   
 
2. Materials and methods 
2.1 Cell lines and drug treatments 
Immortalised embryonic fibroblasts derived from mice (MEFs) knocked out for Bax (Bax-/-), Bak 
(Bak-/-), both genes (DKO) and their wild type (wt) counterparts were obtained from the laboratory of the 
late Prof. Korsmeyer [11,12]. These MEFs have been an important tool in our previous pharmacological 
studies [13,14]. The HeLa cell line was obtained from the American Type Culture Collection (ATCC, 
Manassas, VA, USA). All cell types were grown in 2 mM L-glutamine-supplemented DMEM medium that 
contained 10% of foetal calf serum (FCS). The media and FCS were provided either by Invitrogen or 
Lonza (Barcelona, Spain). PlasmocinTM (5µg/ml) was used as the antibiotic in the medium (InvivoGen, 




atmosphere. The culture dishes and other plastic disposable tools were supplied by Bibby Sterilin 
(Staffordshire, UK) and Becton Dickinson (Franklin Lakes, NJ, USA). PES (2-phenylethynesulfonamide), 
i.e., pifithrin-µ, staurosporine (STS) and Mdivi-1 were purchased from Sigma (St. Louis, MO, USA). The 
stock solutions were prepared in DMSO. The drugs were serially diluted from these stock solutions or 
delivered to the media. The final concentrations are reported in the text and figures. 
 
2.2 Cell death and caspase activity assessment 
To quantify the ratios of cell death in the culture plates, the Cell Titer 96® and Cytotox 96® kits 
were used. Cell Titer 96® measured the reduction of 3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt (MTS). Cytotox 96® measured the 
amount of lactate dehydrogenase (LDH) released from dying cells. Both kits were supplied by Promega 
Biotech Ibérica, SL (Barcelona, Spain). Because MTS reduction alone can lead to misleading 
interpretations due to a drug-induced cessation in cell proliferation, we supplemented the MTS data with 
LDH measurements. The combination of both procedures allows a robust determination of cell death, 
notwithstanding the type of death [13–15]. Apoptosis is a phenotype of cell death that depends on 
effector caspase activation. This activation can be quantified based on the cleavage of a synthetic 
substrate (Ac-DEVD-afc) and the subsequent fluorescence released (DEVDase activity), as we have 
reported previously [16].  
 
2.3 Protein extraction and western blotting 
The cells were lysed in a buffer containing 100 mM Tris/ClH pH 6.8, 1% SDS, 1 µM EDTA, plus a 
cocktail of protease inhibitors from Sigma and subjected to sonication. The protein extract was obtained 
after a centrifugation at 12000 g for 15 minutes. The protein concentration was determined, and an 
equal amount was loaded per lane for SDS 12%-polyacrylamide gel electrophoresis. Following 




immune detection was performed with the following primary antibodies: anti-BAX rabbit polyclonal IgG 
(Upstate catalog 06-499) and anti-BAK rabbit polyclonal IgG (Upstate Catalog 06-536), which were both 
diluted to 2 µg/ml and supplied by Merck Millipore (Barcelona, Spain). Glyceraldehyde-3-P-
dehydrogenase (GAPDH) was detected with the peroxidase-conjugated monoclonal antibody from 
Sigma. This monoclonal antibody was employed at a dilution of 1:4000 to assess the amount of protein 
loaded per lane. The ImmobilonTM reagent from Merck Millipore was employed as the chemiluminescent 
peroxidase substrate. 
 
2.4 Transient transfections 
DKO MEFs were plated in p35 wells at 60-80% confluence. After 24 hours, 4 µg of plasmid DNA 
was transfected using the TurboFect reagent (Fisher Scientific, Barcelona, Spain) according to the 
manufacturer’s instructions. The plasmids employed were hBax C3-EGFP (Addgene #19741), hBax 
S184E C3-EGFP (Addgene #19743), EGFP-Bak (Addgene #32564) and the empty vector (pEGFP-C3). 
These plasmids were originally used to explore the functional domains of the BAX protein [17]. The cells 
were then allowed to recover for an additional 24 hours, harvested, plated at 6000 cells/well in M96 
plates and subjected to drug treatment. 
 
2.5 Microscopic morphological studies 
For electron microscopy, cells from treated or untreated cultures were collected, washed twice in 
PBS (150 mM ClNa, 2.7 mM ClK, 8 mM Na2HPO4, 1.5 mM KH2PO4) and fixed for 30 minutes at 4°C in 
100 mM phosphate buffer (pH 7.4) containing 2.5% glutaraldehyde. After rinsing the pellets twice with 
PBS at 4°C, the cells were post-fixed in buffered OsO4, dehydrated in graded acetone and embedded in 
Durcupan® ACM resin (Fluka, Buchs, Switzerland). Ultrathin sections mounted on copper grids were 
counterstained with uranyl acetate and lead citrate. A transmission electron microscope (Zeiss EM 910) 




For the fluorescence microscopy of mitochondria, plated cells were placed in PBS containing 
MitoTracker® Red (Life Technologies, Barcelona, Spain) at a concentration 50 nM for 30 minutes. After 




3.1 Cell death induction by PES was caspase-independent and more prominent in the DKO MEFs 
To circumscribe the role of BAX and BAK in the cell death process triggered by PES, we 
characterised its lethal effects in DKO MEFs and their wt counterparts. Both cell lines were treated with 
increasing concentrations of PES, and the cell viability was determined after 8 hours of treatment. The 
cell viability was measured using the MTS procedure and found to decrease in a concentration-
dependent manner (Fig. 1A). To confirm this result, both cell lines were subjected to identical PES 
concentrations, and the cell death was measured with the LDH procedure after 24 hours of treatment 
(Fig. 1B). The cell death and viability values were complementary and consistently proved the greater 
resistance of wt MEFs. In parallel, these cell lines were treated with staurosporine (STS) at a 
concentration of 1 µM for 8 hours (MTS assay) and 24 hours (LDH assay). STS is one of the most 
widely accepted inducers of the intrinsic or mitochondrial pathway of apoptosis, i.e., the pathway 
mediated by BAX and BAK. As expected, DKO cells but not the wt MEFs were resistant. 
Because apoptosis can also be triggered in a BAX- and BAK-independent manner via the 
extrinsic pathway, we studied the activation of effector caspases in wt MEFs treated with PES (fig. 1C). 
The cells were treated for 12 hours with increasing concentrations of PES and STS (200 nM) to control 
apoptosis and caspase activation. STS was observed to increase the caspase activity more than 10-fold 
compared to the basal value of the untreated cells. Conversely, the PES-induced values did not surpass 
the basal level, irrespective of the concentration employed. Moreover, they fell below the basal level in a 




involvement of BAX and BAK rule out apoptosis as the lethal mode of action of PES. In addition, PES 
highlighted a pro-survival effect for BAX, BAK, or the combination of these proteins. 
 
3.2 BAX protein was protecting MEFs from PES-induced cell death 
We performed a new series of experiments in order to determine the involvement of BAX, BAK 
or the combination of these proteins in protecting cells from PES. The effects of PES on Bax-/-, Bak-/-, 
DKO and wt MEFs were tested in parallel (Fig. 2A). Bax-/- and DKO MEFs were similarly sensitive and 
displayed the greatest susceptibility to PES lethality. Conversely, Bak-/- and wt MEFs wt were clearly 
more resistant to PES. To better quantify the sensitivity of these cells lines to PES, we calculated the 
drug concentration required to kill 50% of the cell population (LC50).  Based on our data (Fig. 2A), the 
LC50 was 6.5 µM for DKO, 7.25 µM for Bax-/-, 14.5 µM for wt and 21.5 µM for Bak-/- MEFs. Therefore, 
wt MEFs doubled and Bak-/- MEFs approximately tripled the values of their Bax-/- and DKO 
counterparts. In conclusion, the presence of BAX seemed to be the crucial element correlating with 
resistance to PES-induced cell death.  
The content of BAX and BAK proteins was routinely assessed in the four cells lines using 
western blotting and found to be consistent with expected values (Fig. 2B). This determination excluded 
mistakes due to mislabelling or the accidental cross-contamination of the cell lines. However, PES could 
change the cell content of BAX and BAK proteins by modulating their expression or degradation rates. 
The wt MEFs were treated with increasing concentrations of PES for 8 hours, and the content of BAX 
and BAK proteins was assessed with a western blot (Fig. 2C). As shown, PES did not significantly affect 
the amounts of BAX and BAK proteins.  Because epigenetics or other uncontrolled phenomena could 
influence the response to PES in each type of MEF, we adopted another experimental approach. We 
transiently transfected DKO MEFs with plasmids to overexpress the BAX, BAXS184E and BAK proteins. 
BAXS184E contains a Serine 184 to Glutamic mutation in the C terminus transmembrane domain. This 




fused with the green fluorescent protein (GFP), and therefore, the efficiency of the transient transfection 
can be assessed by fluorescence microscopy. Experiments were only continued if the efficiency rated 
50% of the cell population. As shown, the non-mutated Bax gene conferred a statistically significant 
protection to DKO MEFs (Fig. 3A). Neither the BaxS184E nor Bak gene promoted any survival effect 
after being transfected. The effect of STS, a canonical inducer of apoptotic cell death, was tested in 
parallel to assess the function of the transfected proteins. The transfection of the Bax and Bak genes 
increased cell death in accordance with their apoptosis mediating role. The transfection of the 
BaxS184E mutant was significantly less lethal than that of the Bax gene, which agreed with its impaired 
functionality (Fig. 3B). In conclusion, the BAX pro-survival effect in cells treated with PES was proven 
and shown to be dependent on its appropriate insertion into the mitochondrial membranes.  
 
3.3 Mitochondrial fusion was observed in wt MEFs treated with PES 
In our initial studies of PES-induced lethality, wt and DKO MEFs were treated with 30 µM PES 
for 7 hours and subjected to electron microscopy analysis. Healthy, untreated wt MEFs displayed a 
typical fibroblast morphology with a developed reticulum and abundant mitochondria in the cytoplasm. 
The nuclei were quite large and contained discernible heterochromatin condensations located 
preferentially adjacent to the nuclear membrane (Fig. 4A). Upon PES treatment, a prominent 
vacuolisation was observed in the cytoplasm (Fig. 4B). The nuclei lost their peripheral heterochromatin 
but remained well preserved. No apoptotic features were detected. When the resolution of the images 
was increased, abundant multi-lamellar autophagosome structures that characterise autophagy were 
observed (Fig. 4C, arrows). This cell death phenotype reinforced the occurrence of a non-apoptotic type 
of cell death and reproduced the type previously reported in other cells [4]. DKO MEFs subjected to 
PES treatment were also studied and displayed a death pattern similar to the one described for the wt 




displaying cristae with a normal morphology were only found in wt MEFs (Fig. 4D, arrowheads). This 
finding seemed to indicate that mitochondrial fusion was more common if the BAX protein was present. 
 
3.4 Increased mitochondrial fusion had a protective effect on MEFs treated with PES.  
To assess whether mitochondrial fusion protected cells challenged with PES, we relied on the 
Mdivi-1 compound as an inducer of mitochondrial fusion [18]. Following a pre-incubation of 6 hours with 
Mdivi-1 (40 µM), MEFs became significantly resistant to PES treatment (not shown). The resistance was 
even greater if Mdivi-1 was maintained throughout the treatment with PES after the pre-incubation 
period (Fig. 5A). The protective effect of Mdivi-1 was observed in MEFs containing BAX (wt MEFs) and 
those not expressing this protein (Bax-/- and DKO MEFs). However, the Mdivi-1 protection was 
significantly increased in wt compared to Bax-/- or DKO MEFs. To assess the effect of Mdivi-1 on 
mitochondrial fusion, wt MEFs were subjected to the Mdivi-1 pre-incubation and stained with a 
mitochondrial dye (MitoTracker®). Control, untreated cells displayed the spotted pattern expected if 
mitochondria are not fused (Fig. 5B). After 24 hours of Mdivi-1 treatment, a pattern of branched and 
filamentous mitochondria was observed (Fig. 5C). This pattern indicated an extreme condition of 
mitochondrial fusion. Finally, HeLa cells were also treated with increasing concentrations of PES, and a 
decrease in cell viability was observed. As reported above for the MEFs, HeLa cells were also protected 
from PES toxicity by the 6 hours of pre-incubation and maintenance with Mdivi-1 (Fig. 5D). In 




The main purpose of this work was to assess the role of BAX and BAK proteins in the death 
process induced by PES. MEFs defective in BAX, BAK, both proteins and their wt counterparts were 




death. Moreover, PES-induced cell lethality occurred without the activation of effector caspases. 
Therefore, apoptosis could be excluded as the mechanism of cell death triggered by PES in our model. 
Unexpectedly, BAX significantly protected cells from PES treatment. This result suggests that the 
cellular functions of BAX differ from those involved in mitochondrial outer membrane permeabilisation 
(MOMP) and apoptosis induction. Although somewhat unexpected, a pro-survival function for BAX has 
previously been reported. For example, hypoplasia due to cell death was observed in specific tissues in 
early studies of Bax-/- mice [19]. A survival effect for BAX was also observed in specific neuronal 
populations undergoing neurotrophic factor deprivation or Sindbis virus infection [20,21]. Finally, BAX 
overexpression reduced the ratios of cell death triggered by chemical compounds, such as Nigericin and 
6-hydroxydopamine [22,23]. However, these reports do not provide consistent evidence about the 
nature of the pro-survival effect of BAX, and the issue remains very obscure.  
We have shown that BAX needed to be inserted into the mitochondrial membranes in order to 
protect cells from PES treatment. Moreover, we demonstrated the ability of mitochondrial fusion caused 
by Mdivi-1 to counteract the toxic effects of PES. Based on these facts, we propose that BAX exerts a 
pro-survival effect via mitochondrial fusion. In support of our hypothesis, BAX is known to interact with 
the molecular machinery that controls mitochondrial fusion in healthy cells [24]. However, BAX is also 
located at the fission sites and involved in the extreme fragmentation of mitochondria observed in 
apoptosis [25,26].  Therefore, the involvement of BAX in mitochondrial dynamics is clear, but the final 
outcome seems controversial. Moreover, most members of the Bcl-2 family seem to participate in the 
regulation of mitochondrial dynamics, but a clear picture cannot yet be drawn regarding their precise 
involvement [27–29]. In Fig. 5A, we showed that Mdivi-1 more effectively prevented PES lethality when 
the BAX protein was present (wt MEFs), but BAX was not required for the protective effect of Mdivi-1 
(Bax-/- or DKO MEFs). Mdivi-1 can likely promote mitochondrial fusion in the absence of BAX, although 
less efficiently. Finally, the protective effect of Mdivi-1 is not circumscribed to MEFs because it was also 




PES is believed to generate non-apoptotic, non-autophagic cell death by promoting proteotoxic 
stress [4,6]. In this context, we found BAX and mitochondrial fusion converging to prevent this type of 
cell death. In a previous report, BAX and mitochondrial fusion mediated by Mdivi-1 promoted necrotic 
cell death. In this report, ionomycin and the subsequent overload of cytoplasmic Ca2+ were the inducers 
of necrosis. [30]. How can these opposite findings be conciliated? We propose that mitochondrial fusion 
generates opposite results depending on the death stimuli. The mitochondrial dynamics need to be 
studied further. For example, its role as a modulator of the cellular response to toxic insults awaits a 
systematic characterisation. 
Normal T lymphocytes were found to be more resistant to PES than were leukemic ones [9]. 
Similarly, non-transformed fibroblasts were far more resistant than the 10 tumour-derived cell lines 
tested in parallel [4]. The DKO MEFs studied herein are known for their resistance to chemotherapy. 
Therefore, they can be considered to display an aggressive oncogenic phenotype [31]. We have herein 
reported the increased sensitivity of Bax-/- and DKO MEFs to PES. The deficiency of BAX becomes a 
crucial factor to explain this increased sensitivity. In conclusion, we are expanding the profile of PES as 
a promising drug for its anticancer selectivity. Specifically, cancer cells harbouring oncogenic BAX 
deletions or mutations are expected to preferentially succumb to PES. 
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Figure legends 
Fig. 1. MEFs defective in both, BAX and BAK proteins, displayed increased sensitivity to PES toxicity. 
As stated, wt and DKO MEFs were treated with increasing concentrations of PES and STS (1 µM).  Cell 
viability was determined using the MTS procedure after 8 hours of treatment. The bar value is the mean 
± SEM, n = 4, each n = 5-6 replicates (A). Cell death was determined by the LDH procedure after 24 
hours of treatment. The bar value is the mean ± SEM, n = 4, each n = 3 replicates (B). PES did not 
activate effector caspases in wt MEFs. As stated, wt MEFs were treated with increasing concentrations 




quantified in arbitrary fluorescent units (a.f.u.) The bar value is the mean ± SEM of 6 replicates (C). 
Student’s t-test: P < 0.05, P < 0.01, P < 0.001. 
 
Fig. 2. MEFs deficient in BAX protein displayed increased sensitivity to PES. DKO, Bax-/-, Bak-/- and wt 
MEFs were subjected to increasing concentrations of PES as stated in the graph. Cell viability was 
measured using the MTS procedure after 8 hours of treatment.  The values are the mean ± SEM, n = 6, 
each n = 5-6 replicates. Student’s t-test is referred to DKO values: P < 0.05, P < 0.01 (A). BAX and 
BAK content assessment. Protein extracts were obtained from DKO, Bax-/-, Bak-/- and wt MEFs and 
analysed using western blots with antibodies recognising BAX and BAK protein, as indicated (B). PES 
treatment did not affect the BAX and BAK contents. As stated, wt MEFs were treated for 8 hours with 
increasing concentrations of PES, and the proteins were extracted and analysed by western blotting as 
stated above (C) The amount of GAPDH was detected via immunoblotting to assess the amount of 
protein loaded per lane. 
 
Fig. 3. BAX protein conferred resistance to PES-induced lethality to the cells. DKO MEFs were 
transiently transfected with the genes indicated in the x-axis. The efficiency of transfection approached 
50% of the cells in culture. After a treatment with PES (7.5 µM) for 24 hours, the cell viability was 
assessed using the MTS procedure (A). As a functional control, the cells were treated in parallel with 
STS (100nM) for 24 hours and subjected to the MTS test (B). The bar value is the mean ± SEM, n = 1, 
n = 5-6 replicates, representative of 3 independent experiments. Unless otherwise indicated, Student’s 
t-test is referred to control: P < 0.001. 
 
Fig. 4. Transmission electron microscopy of wt MEFs treated with PES. Control morphology of 
untreated wt MEFs. Nu: Nucleus, h: heterochromatin, m: mitochondria. Bar = 1.2 µm (A). Cell in an 




the cytoplasm was severely disrupted by vacuolisation, as indicated with asterisks. Nu: Nuclear 
chromatin. Bar = 1.8 µm (B). PES promoted the accumulation of autophagic vesicles (asterisks) with a 
characteristic multilamellar content (arrows). Bar = 0.16 µm (C). Fused and elongated mitochondria with 
preserved cristae were found after PES treatment (circumscribed by arrowheads). Bar = 0.36 µm (D). 
 
Fig. 5. Mdivi-1 induces mitochondrial fusion and cell resistance to death induction by PES. DKO, Bax-/- 
and wt MEFs were pre-incubated for 6 hours in Mdivi-1 (40 µM) (white bars) or DMSO vehicle (black 
bars). PES was then added for 12 hours, and the cell viability measured using the MTS procedure. The 
concentration of PES was 8 µM in Bax-/- and DKO MEFs. To equalise the cell viability rates in the 
absence of Mdivi-1, the concentration of PES was 12.5 µM in wt MEFs. The bar value is the mean ± 
SEM, n = 2, each n = 3 replicates. Student’s t-test: P < 0.001 (A). Control untreated wt MEFs 
stained with MitoTracker® dye. Bar = 100 µm (B). Fused mitochondria in wt MEFs, incubated in Mdivi-1 
(40 µM) and stained with MitoTracker®. Bar = 100 µm (C). HeLa cells were also pre-incubated for 6 
hours with Mdivi-1 (white bars) or DMSO vehicle (black bars) as stated above. The cells were then 
treated with PES at the indicated concentrations, and the cell viability was determined. The bar value is 

































Fig. 5.  
 
 
